Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience

• DOI: 10.1007/s00404-021-06241-1
• Publication Date: 2021-09-16T16:06:39Z
• Authors: Sally Kempa; Eva Brix; Norbert Heine; Vanessa Hösl; Catharina Strauss; Andreas Eigenberger; Vanessa Brébant; Stephan Seitz; Lukas Prantl
• Keywords: Distant metastasis

Abstract Purpose The aim of our study was to examine the surgical outcome and complications (efficiency) as well incidence locoregional recurrence distant metastases (oncological safety) in patients who underwent autologous fat grafting (AFG) breast following cancer surgery. Methods In monocentric cohort study, retrospective prospective data were collected from all consecutive AFG after between 2008 2020; a total 93 met inclusion criteria. Results Our long-term results showed no increase tumor studied collective when compared available literature. We observed 1 local (1.1%), 2 (2.2%), tumor-related death (1.1%). There high degree patient satisfaction; 67.12% reported adequate satisfaction with grafting. Conclusion Currently, knowledge, this is longest follow-up time (mean 6.7 years 11.5 resection). clinical will contribute improve evidence broad field AFG, adipose stem cell research. Consistent literature review shows clear tendency trial low rate metastasis use AFG. seems be safe procedure also treatment.